Amended in Senate April 22, 2015

Amended in Senate March 23, 2015

Senate BillNo. 253


Introduced by Senator Monning

(Principal coauthor: Assembly Member Chiu)

(Coauthor: Senator Beall)

(Coauthor: Assembly Member Gatto)

February 18, 2015


An act to amend Section 369.5 of the Welfare and Institutions Code, relating to juveniles.

LEGISLATIVE COUNSEL’S DIGEST

SB 253, as amended, Monning. Dependent children: psychotropic medication.

Existing law establishes the jurisdiction of the juvenile court, which may adjudge children to be dependents of the court under certain circumstances, including when the child suffered or there is a substantial risk that the child will suffer serious physical harm, or a parent fails to provide the child with adequate food, clothing, shelter, or medical treatment. Existing law authorizes only a juvenile court judicial officer to make orders regarding the administration of psychotropic medications for a dependent child who has been removed from the physical custody of his or her parent. Existing law requires the court authorization for the administration of psychotropic medication to a child be based on a request from a physician, indicating the reasons for the request, a description of the child’s diagnosis and behavior, the expected results of the medication, and a description of any side effects of the medication.

This bill would require that an order authorizing the administration of psychotropic medications to a dependent child be granted only upon the demonstration of clear and convincing evidence thatbegin delete specified criteria are met, includingend deletebegin insert administration of the medication is in the best interest of the child and the court determines that specified requirements have been met, includingend insert a requirement that the prescribing physicianbegin delete attest under penalty of perjuryend deletebegin insert confirmsend insert that he or she has conducted a comprehensive evaluation of the child, as specified. The bill would prohibit the court from authorizing the administration of psychotropic medications to a child under other specified circumstances, unless a 2nd independent medical opinion is obtained from a child psychiatrist or a psychopharmacologist. The bill would prohibit the court from authorizing the administration of a psychotropic medication unless the court is provided documentation that appropriate screenings and tests for the child have been completed no more than 30 days prior to submission of the request to the court. The bill would impose additional requirements on the court to implement these provisions and to conduct review hearings, as specified. The bill would require the Judicial Council to adopt rules to implement these provisions.

begin delete

By requiring the attestation of the prescribing physician under penalty of perjury, as described above, this bill would create a crime and impose a state-mandated local program.

end delete
begin delete

The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.

end delete
begin delete

This bill would provide that no reimbursement is required by this act for a specified reason.

end delete

Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: begin deleteyes end deletebegin insertnoend insert.

The people of the State of California do enact as follows:

P2    1

SECTION 1.  

Section 369.5 of the Welfare and Institutions
2Code
is amended to read:

3

369.5.  

(a) If a child is adjudged a dependent child of the court
4under Section 300 and the child has been removed from the
5physical custody of the parent under Section 361, only a juvenile
6court judicial officer shall have authority to make orders regarding
7the administration of psychotropic medications for that child. The
8juvenile court may issue a specific order delegating this authority
9to a parent upon making findings on the record that the parent
10poses no danger to the child and has the capacity to authorize
P3    1psychotropic medications. Court authorization for the
2administration of psychotropic medication shall be based on a
3request from a physician, indicating the reasons for the request, a
4description of the child’s diagnosis and behavior, the expected
5results of the medication, and a description of any side effects of
6the medication. On or before July 1, 2016, the Judicial Council
7shall adopt rules of court and develop appropriate forms for
8implementation of this section. Whenever the court authorizes the
9administration of a psychotropic medication, it shall ensure that
10the administration of the psychotropic medication is only one part
11of a comprehensive treatment plan for the child that shall include
12and specify the psychosocial services the child will receive in
13addition to any authorized medication.

14(b) (1) An order authorizing the administration of psychotropic
15medications pursuant to this section shall only be granted on clear
16and convincing evidencebegin delete of all of the following:end deletebegin insert that administration
17of the medication is in the best interest of the child based on a
18determination that the anticipated benefits of the psychotropic
19medication outweigh the short- and long-term risks associated
20with the medications.end insert

begin insert

21(2) An order authorizing the administration of psychotropic
22medications pursuant to this section shall only be granted if the
23court determines all of the following:

end insert

24(A) The medication is not being used as punishment, for the
25convenience of staff, as a substitute for other, less invasive
26treatments, or in quantities or dosages that interfere with the child’s
27treatment program.

begin delete

28(B) If the child is 12 years of age or older, the child, after being
29advised of alternative treatments and informed of the benefits and
30 risks of the medication, understands his or her right to refuse the
31medication, and has given his or her written informed consent.

end delete
begin insert

32(B) The court is provided documentation confirming the child’s
33caregiver has been informed, and the child has been informed in
34an age and developmentally appropriate manner, about the
35recommended medications, the anticipated benefits, the nature,
36degree, duration, and probability of side effects and significant
37risks commonly known by the medical profession, and of
38psychosocial treatments to be considered concurrently with or as
39an alternative to the medication.

end insert
begin insert

P4    1(i) The documentation shall state that the child and the child’s
2caregiver have been asked whether either have concerns regarding
3the medication, and if so, shall describe the nature of those
4concerns. The documentation shall confirm that the child has been
5informed of the right to request a hearing pursuant to subdivision
6(g).

end insert
begin insert

7(ii) The documentation shall include the written informed
8consent of a child who is 14 years of age or older, after being
9advised pursuant to this subparagraph.

end insert

10(C) The prescribing physician submitting the request for
11psychotropic medicationbegin delete attests under penalty of perjuryend deletebegin insert confirmsend insert
12 that he or she conducted a comprehensive examination of the child
13in compliance with Section 2242 of the Business and Professions
14Codebegin delete that takes into account the child’s trauma and medication
15history and is based upon multiple sources, including, among
16others, the child’s medical records, the child, the child’s parents,
17relatives, teacher, caregiver or caregivers, past prescribers of
18psychotropic medication, or other health care providers. The
19prescribing physician shall also attest that the dosage or dosage
20range requested is appropriate for the child.end delete
begin insert and consistent with
21the Psychiatric Evaluation and Diagnosis provisions included in
22the Guidelines for the Use of Psychotropic Medication with
23Children and Youth in Foster Care issued by the state, which takes
24into account all of the following:end insert

begin insert

25(i) The child’s trauma history.

end insert
begin insert

26(ii) The child’s medical records, including medication history.

end insert
begin insert

27(iii) Multiple sources of information, including, but not limited
28to, the child, the child’s parents, relatives, teacher, caregiver or
29caregivers, past prescribers of psychotropic medication, or other
30health care providers.

end insert
begin delete

31(D) The short- and long-term risks associated with the use of
32psychotropic medications by the child does not outweigh the
33 reported benefits to the child.

34(E) There are no less invasive and effective treatment options
35available to meet the needs of the child.

end delete
begin insert

36(D) The prescribing physician shall also confirm all of the
37following:

end insert
begin insert

38(i) There are no less invasive and effective treatment options
39available to meet the needs of the child.

end insert
begin insert

P5    1(ii) The dosage or dosage range requested is appropriate for
2the child.

end insert
begin insert

3(iii) The short- and long-term risks associated with the use of
4psychotropic medications by the child does not outweigh the
5reported benefits to the child.

end insert
begin insert

6(iv) All appropriate lab screenings, measurements, or tests for
7the child have been completed in accordance with accepted medical
8guidelines.

end insert
begin insert

9(E) A plan is in place for regular monitoring of the child’s
10medication and psychosocial treatment plan, the effectiveness of
11the medication and psychosocial treatment, and any potential side
12effects of the medication, by the physician in consultation with the
13caregiver, mental health care provider, and others who have
14contact with the child, as appropriate.

end insert

15(2) The person or entity submitting the request for authorization
16of the administration of psychotropic medication shall bear the
17burden of proof established in this section.

18(c) A court shall not issue an order authorizing the administration
19of psychotropic medications for a child unless a second
20independent medical opinion is obtained from a child psychiatrist
21or a psychopharmacologist if one or more of the following
22circumstances exist:

23(1) The request is for any class of psychotropic medication for
24a child who is five years of age or younger.

25(2) The request would result in the child being administered
26three or more psychotropic medications concurrently.

27(3) The request is for the concurrent administration of any two
28drugs from the same class unless the request is for medication
29tapering and replacement that is limited to no more than 30 days.

30(4) The request is for a dosage that exceeds the amount
31recommended for children.

32(5) The request is for the administration of a psychotropic
33medicationbegin insert that is subject to a federal Food and Drug
34Administration black box warning requirement or is for the
35administration of an antipsychotropoic medicationend insert
for a use that
36is not approved by the federal Food and Drug Administration for
37children or adolescents.

38(d) The court shall not authorize the administration of the
39psychotropic medication unless the court is provided
40documentation that all of the appropriate lab screenings,
P6    1measurements, or tests for the child have been completed in
2accordance with accepted medical guidelines no more than 30 days
3prior to submission of the request to the court.

4(e) (1) No later thanbegin delete 45end deletebegin insert 60end insert days after the authorization of a new
5psychotropic medication is granted or at the next review hearing
6scheduled for the child pursuant to Section 366, 366.21, 366.22,
7or 366.31,begin delete whichever is earlier,end deletebegin insert if scheduled no earlier than 45
8days after the authorization of a new psychotropic medication,end insert
the
9court shall conduct a review hearing to determine all of the
10following:

11(A) Whether the child is taking the medication or medications.

begin insert

12(B) Whether psychosocial services and other aspects of the
13child’s treatment plan have been provided to the child.

end insert
begin delete

14(B)

end delete

15begin insert(C)end insert To what extent the symptoms for which the medication or
16medications were authorized have been alleviated.

begin delete

17(C)

end delete

18begin insert(D)end insert What, if any, adverse effects the child has suffered.

begin delete

19(D)

end delete

20begin insert(E)end insert Any steps taken to address those effects.

begin delete

21(E)

end delete

22begin insert(F)end insert The date or dates of followup visits with the prescribing
23physician since the medication or medications were authorized.

begin insert

24(G) Whether the appropriate followup laboratory screenings
25have been performed and their findings.

end insert

26(2) If based upon this review, the court determines that the
27proffered benefits of the medication have not been demonstrated
28or that the risks of the medication outweigh the benefits, the court
29shall reconsider, modify, or revoke its authorization for the
30administration of medication.

31(f) (1) In counties in which the county child welfare agency
32completes the request for authorization for the administration of
33psychotropic medication, the agency is encouraged to complete
34the request within three business days of receipt from the physician
35of the information necessary to fully complete the request.

36(2) Nothing in this subdivision is intended to change current
37local practice or local court rules with respect to the preparation
38and submission of requests for authorization for the administration
39of psychotropic medication.

P7    1(g) Within seven court days from receipt by the court of a
2completed request, the juvenile court judicial officer shall either
3approve or deny in writing a request for authorization for the
4administration of psychotropic medication to the child, or shall,
5upon a request by the parent, the legal guardian, or the child’s
6attorney, or upon its own motion, set the matter for hearing.

7(h) Psychotropic medication or psychotropic drugs are those
8medications administered for the purpose of affecting the central
9nervous system to treat psychiatric disorders or illnesses. These
10medications include, but are not limited to, anxiolytic agents,
11antidepressants, mood stabilizers, antipsychotic medications,
12anti-Parkinson agents, hypnotics, medications for dementia, and
13psychostimulants.

14(i) Nothing in this section is intended to supersede local court
15rules regarding a minor’s right to participate in mental health
16decisions.

17(j) This section shall not apply to nonminor dependents, as
18defined in subdivision (v) of Section 11400.

begin delete
19

SEC. 2.  

No reimbursement is required by this act pursuant to
20Section 6 of Article XIII B of the California Constitution because
21the only costs that may be incurred by a local agency or school
22district will be incurred because this act creates a new crime or
23infraction, eliminates a crime or infraction, or changes the penalty
24for a crime or infraction, within the meaning of Section 17556 of
25the Government Code, or changes the definition of a crime within
26the meaning of Section 6 of Article XIII B of the California
27Constitution.

end delete


O

    97